Quantinuum (NASDAQ:QNT – Get Free Report) was upgraded by equities research analysts at UBS Group to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.
Several other brokerages have also weighed in on QNT. Mizuho began coverage on Quantinuum in a research report on Monday. They issued an “outperform” rating and a $90.00 price objective for the company. Rosenblatt Securities assumed coverage on Quantinuum in a report on Monday. They set a “buy” rating and a $155.00 price target for the company. Needham & Company LLC assumed coverage on Quantinuum in a research note on Monday. They issued a “buy” rating and a $100.00 price objective for the company. JPMorgan Chase & Co. started coverage on shares of Quantinuum in a research report on Monday. They issued an “overweight” rating and a $97.00 price objective on the stock. Finally, Craig Hallum assumed coverage on Quantinuum in a research note on Monday. They issued a “buy” rating and a $100.00 price target on the stock. Four equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $98.75.
Check Out Our Latest Analysis on Quantinuum
Quantinuum Price Performance
Insiders Place Their Bets
In other news, Director Manish H. Bhatia bought 20,000 shares of Quantinuum stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $60.00 per share, with a total value of $1,200,000.00. Following the acquisition, the director owned 25,833 shares of the company’s stock, valued at approximately $1,549,980. This trade represents a 342.88% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kenneth D. Denman purchased 14,000 shares of the business’s stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $60.00 per share, for a total transaction of $840,000.00. Following the transaction, the director owned 19,833 shares of the company’s stock, valued at $1,189,980. This trade represents a 240.01% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders bought 411,032 shares of company stock worth $24,661,920.
Key Stories Impacting Quantinuum
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Several major firms initiated or upgraded coverage on Quantinuum with upbeat ratings, including “strong-buy” calls from Cantor Fitzgerald, Evercore, and Jefferies, plus buy/overweight ratings from JPMorgan, Bank of America, Needham, Mizuho, Craig Hallum, Rosenblatt, and others. Many of these targets imply meaningful upside from recent levels.
- Positive Sentiment: Analysts highlighted Quantinuum as a key quantum-computing name, with one report calling it a new Wall Street favorite and another noting triple-digit upside potential, reinforcing the stock’s momentum. Article Title
- Positive Sentiment: Recent insider-buying headlines also supported sentiment, including reports of about $25 million in post-IPO insider purchases and a congressman’s disclosed purchase of Quantinuum stock, which investors may interpret as a confidence signal. Article Title
- Positive Sentiment: Coverage linking the stock to a recent quantum-computing executive order and noting a sharp share-price move added to the momentum trade around the name. Article Title
About Quantinuum
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
Recommended Stories
- Five stocks we like better than Quantinuum
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
